Table 3. Comparison of adherence and virological failure between arms.

		Adherent at the end of the follow-up period				P
		MT		TT
		N	%	N	%
Last VL undetectable (<50 copies/mL)	No (> 50)	11	12.5	3	7.0
	Yes (< 50)	77	87.5	40	93.0	0.337
Undetectable VL during the study	Yes	73	83.0	39	90.7
	No	15	17.0	4	9.3	0.237
Virological failure (>500 copies/mL)	Yes	1	1.1	0	0.0
	No	88	98.9	43	100.0	1.000
Virological failure (>200 copies/ml)	Yes	3	3.4	0	0.0
	No	86	96.6	43	100.0	0.551
Virological failure (>50 copies/mL)	Yes	6	6.7	1	2.3
	No	83	93.3	42	97.7	0.426
		Non-adherent at the end of the follow-up period				P
		MT		TT
		N	%	N	%
Last VL undetectable (<50 copies/mL)	No (> 50)	8	21.1	5	26.3
	Yes (< 50)	30	78.9	14	73.7	0.655
Undetectable VL during the study	Yes	27	71.1	13	68.4
	No	11	28.9	6	31.6	0.838
Virological failure (>500 copies/mL)	Yes	1	2.6	0	0.0
	No	37	97.4	19	100.0	1.000
Virological failure (>200 copies/ml)	Yes	1	2.6	0	0.0
	No	37	97.4	19	100.0	1.000
Virological failure (>50 copies/mL)	Yes	4	10.5	2	10.5
	No	34	89.5	17	89.5	1.000

Intent-to-treat analysis.